Neoadjuvant radiotherapy in ER+, HER2+, and triple-negative -specific breast cancer based humanized tumor mice enhances anti-PD-L1 treatment efficacy
Christina Bruß(University Hospital Regensburg), Anja K. Wege(Cancer Research UK)
Cited by 7
Related Papers
Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy
|Cell Reports|2019|297
Humanized tumor mice—A new model to study and manipulate the immune response in advanced cancer therapy
|International Journal of Cancer|2011|105